Literature DB >> 11108532

Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis.

E Dequeker1, H Cuppens, J Dodge, X Estivill, M Goossens, P F Pignatti, H Scheffer, M Schwartz, M Schwarz, B Tümmler, J J Cassiman.   

Abstract

These recommendations for quality improvement of cystic fibrosis genetic diagnostic testing provide general guidelines for the molecular genetic testing of cystic fibrosis in patients/individuals. General strategies for testing as well as guidelines for laboratory procedures, internal and external quality assurance, and for reporting the results, including the requirements of minimal services in mutation testing, the nomenclature for describing mutations, procedures to control false-positive amplification reactions and to validate tests, and guidelines to implement a quality system in a molecular diagnostic laboratory are reviewed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108532     DOI: 10.1038/sj.ejhg.5200487

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

1.  Variability in the use of CE-marked assays for in vitro diagnostics of CFTR gene mutations in European genetic testing laboratories.

Authors:  Jana Camajova; Sarah Berwouts; Gert Matthijs; Milan Macek; Elisabeth Dequeker
Journal:  Eur J Hum Genet       Date:  2008-12-03       Impact factor: 4.246

2.  Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations.

Authors:  Els Dequeker; Manfred Stuhrmann; Michael A Morris; Teresa Casals; Carlo Castellani; Mireille Claustres; Harry Cuppens; Marie des Georges; Claude Ferec; Milan Macek; Pier-Franco Pignatti; Hans Scheffer; Marianne Schwartz; Michal Witt; Martin Schwarz; Emmanuelle Girodon
Journal:  Eur J Hum Genet       Date:  2008-08-06       Impact factor: 4.246

3.  Molecular basis of cystic fibrosis disease: an Indian perspective.

Authors:  R Prasad; H Sharma; G Kaur
Journal:  Indian J Clin Biochem       Date:  2010-11-19

Review 4.  Cystic fibrosis: terminology and diagnostic algorithms.

Authors:  K De Boeck; M Wilschanski; C Castellani; C Taylor; H Cuppens; J Dodge; M Sinaasappel
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

5.  Assessment of Correlation between Sweat Chloride Levels and Clinical Features of Cystic Fibrosis Patients.

Authors:  Manzoor A Raina; Mosin S Khan; Showkat A Malik; Ab Hameed Raina; Mudassir J Makhdoomi; Javed I Bhat; Syed Mudassar
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 6.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

Review 7.  [Molecular genetics principles in cystic fibrosis. An example of genetic illness in pneumology].

Authors:  B Tümmler; M Stuhrmann
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

8.  Survey of CF mutations in the clinical laboratory.

Authors:  Klaus Huber; Borka Mirkovic; Rhea Nersesian; Angela Myers; Randall Saiki; Kurt Bauer
Journal:  BMC Clin Pathol       Date:  2002-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.